Antibiotics | Free Full-Text | Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis - Pseudomonas aeruginosa Severe Sepsis
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial | Intensive Care Medicine - antibiotic therapy
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium - ScienceDirect - Pseudomonas aeruginosa: resistance and
Antibiotics used for the Treatment of Pseudomonas Aeruginosa | GrepMed - Pseudomonas Aeruginosa | GrepMed
Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital | BMC Infectious Diseases | Full Text - Measuring the in-hospital costs of
Antibiotics for the treatment of Pseudomonas aeruginosa infections in... | Download Table - Pseudomonas aeruginosa infections
Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa - ScienceDirect - Multidrug-Resistant Pseudomonas
Pathogens | Free Full-Text | Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review - Pseudomonas aeruginosa Biofilm
Antimicrobial agents with activity against Pseudomonas aeruginosa... | Download Scientific Diagram - against Pseudomonas aeruginosa
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine - Pseudomonas aeruginosa
Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports - drug-resistant Pseudomonas aeruginosa
Treatment heterogeneity in patients with Pseudomonas aeruginosa pneumonia. | Download Scientific Diagram - Pseudomonas aeruginosa pneumonia
A 10-year microbiological study of Pseudomonas aeruginosa strains revealed the circulation of populations resistant to both carbapenems and quaternary ammonium compounds | Scientific Reports - Pseudomonas aeruginosa
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review - ScienceDirect - Pseudomonas aeruginosa
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics | Signal Transduction and Targeted Therapy - Pseudomonas aeruginosa: pathogenesis
Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics | Critical Care | Full Text - Airway Pseudomonas aeruginosa density
Antibiotics | Free Full-Text | Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal - Pseudomonas aeruginosa Infections
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics | Signal Transduction and Targeted Therapy - Pseudomonas aeruginosa: pathogenesis
Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment - ScienceDirect - Pseudomonas aeruginosa: Infections and
Antibiotics | Free Full-Text | Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal - Pseudomonas aeruginosa Infections
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients | European Respiratory Society - risk factors for Pseudomonas aeruginosa
Pseudomonas aeruginosa Infection | HAI | CDC - Pseudomonas aeruginosa Infection | HAI
Pseudomonas Aeruginosa Infection, Symptoms and Treatment - Pseudomonas Aeruginosa Infection
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections | BMC Microbiology | Full Text - Pseudomonas aeruginosa infections
Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa | Nature Communications - Personalized aerosolised bacteriophage
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging - Global Pseudomonas Aeruginosa Infection
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis | European Respiratory Society - Pseudomonas aeruginosa infections
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections | Drugs - Pseudomonas aeruginosa Infections
Pathogens | Free Full-Text | Pseudomonas aeruginosa Infections in Cancer Patients - Pseudomonas aeruginosa Infections
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients | European Respiratory Society - risk factors for Pseudomonas aeruginosa
Studies regarding the effect of new antibiotics on Pseudomonas... | Download Table - antibiotics on Pseudomonas
Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect - Pseudomonas aeruginosa infection
-
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics | Signal Transduction and Targeted Therapy - Pseudomonas aeruginosa: pathogenesis
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa | European Respiratory Society - Pseudomonas aeruginosa
Southwest Journal of Pulmonary, Critical Care and Sleep - Imaging - Medical Image of the Month: Cavitating Pseudomonas aeruginosa Pneumonia - Cavitating Pseudomonas aeruginosa Pneumonia
Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study | Trials | Full Text - Impact of the duration of antibiotics
Flow chart of the exclusion of patients with Pseudomonas aeruginosa | Download Scientific Diagram - Pseudomonas aeruginosa
Pharmacological effects and mechanism of Maxing Shigan decoction in the treatment of Pseudomonas aeruginosa pneumonia - ScienceDirect - Pseudomonas aeruginosa pneumonia
Antibiotics | Free Full-Text | Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections - against Pseudomonas aeruginosa Infections
PDF) Community-acquired Pseudomonas aeruginosa pneumonia in a previously healthy young woman - PDF) Community-acquired Pseudomonas
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update | Drugs - Pseudomonas aeruginosa Infections
ICS dose may be risk factor for P. aeruginosa infection in severe COPD - P. aeruginosa infection in severe COPD
Pseudomonas aeruginosa: a pathogen making itself at home: Trends in Immunology - Pseudomonas aeruginosa: a pathogen
A clinical approach to managing Pseudomonas aeruginosa infections | British Journal of Hospital Medicine - A clinical approach to managing
Antibiotics | Free Full-Text | Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal - Pseudomonas aeruginosa Infections
Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient - ScienceDirect - Pseudomonas aeruginosa coinfection
Southwest Journal of Pulmonary, Critical Care and Sleep - Imaging - Medical Image of the Month: Cavitating Pseudomonas aeruginosa Pneumonia - Cavitating Pseudomonas aeruginosa Pneumonia
A case report of community-acquired Pseudomonas aeruginosa pneumonia complicated with MODS in a previously healthy patient and related literature review | BMC Infectious Diseases | Full Text - A case report of community-acquired
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa | European Respiratory Society - Pseudomonas aeruginosa
-
Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa - ScienceDirect - Pseudomonas aeruginosa
PDF) A continuous publication, open access, peer-reviewed journal Citation How to manage Pseudomonas aeruginosa infections ACCESS ONLINE | Benjamin Paak - Academia.edu - peer-reviewed journal Citation
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa | European Respiratory Society - Pseudomonas aeruginosa
Treatment heterogeneity in patients with Pseudomonas aeruginosa pneumonia. | Download Scientific Diagram - Pseudomonas aeruginosa pneumonia
Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies - Pseudomonas aeruginosa bacteraemia
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa | European Respiratory Society - Pseudomonas aeruginosa
Pseudomonas Aeruginosa Infection Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends - Pseudomonas Aeruginosa Infection
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections | Drugs - Pseudomonas aeruginosa Infections
Incidence and risk factors for Pseudomonas aeruginosa... | Download Table - risk factors for Pseudomonas aeruginosa
A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia | BMC Infectious Diseases | Full Text - Pseudomonas aeruginosa infection
An Introduction to Aspiration Pneumonia - An Introduction to Aspiration Pneumonia
-
Rate of development of antibiotic resistance over time for pneumonia... | Download Scientific Diagram - antibiotic resistance
